Bifidobacterium bifidum OLB6378 simultaneously enhances systemic and mucosal humoral immunity in low birth weight infants: A non-randomized study

Nutrients

Volumn 9, Issue 3, 2017, Pages

  Tanaka, Katsunori ^a   Tsukahara, Takamitsu ^b   Yanagi, Takahide ^a   Nakahara, Sayuri ^a   Furukawa, Ouki ^a   Tsutsui, Hidemi ^a   Koshida, Shigeki ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Heat treated; Humoral immunity; Non live bacteria; Probiotics; Sepsis; Serum IgG; Stool secretory IgA

Indexed keywords

IMMUNOGLOBULIN G; PROBIOTIC AGENT; SECRETORY IMMUNOGLOBULIN;

APGAR SCORE; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM; BIFIDOBACTERIUM BIFIDUM OLB6378; BODY WEIGHT; CESAREAN SECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; HUMORAL IMMUNITY; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; NEONATAL INTENSIVE CARE UNIT; NEPHELOMETRY; OUTCOME ASSESSMENT; SUPPLEMENTATION; BIFIDOBACTERIUM BIFIDUM; BLOOD; CONTROLLED CLINICAL TRIAL (TOPIC); IMMUNOLOGY; INCIDENCE; MUCOSAL IMMUNITY; SEPSIS; SPECIMEN HANDLING; TREATMENT OUTCOME;

BIFIDOBACTERIUM BIFIDUM; FEMALE; HUMANS; IMMUNITY, HUMORAL; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN G; INCIDENCE; INFANT; INFANT, LOW BIRTH WEIGHT; MALE; NON-RANDOMIZED CONTROLLED TRIALS AS TOPIC; PROBIOTICS; SEPSIS; SPECIMEN HANDLING; TREATMENT OUTCOME;

EID: 85014015064     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9030195     Document Type: Article

References (32)

1. Camacho-Gonzalez, A.; Spearman, P.W.; Stoll, B.J. Neonatal infectious diseases: Evaluation of neonatal sepsis. Pediatr. Clin. N. Am. 2013, 60, 367–389. [CrossRef] [PubMed]
2. Hotoura, E.; Giapros, V.; Kostoula, A.; Spirou, P.; Andronikou, S. Tracking changes of lymphocyte subsets and pre-inflammatory mediators in full-term neonates with suspected or documented infection. Scand. J. Immunol. 2011, 73, 250–255. [CrossRef] [PubMed]
3. Hotoura, E.; Giapros, V.; Kostoula, A.; Spyrou, P.; Andronikou, S. Pre-inflammatory mediators and lymphocyte subpopulations in preterm neonates with sepsis. Inflammation 2012, 35, 1094–1101. [CrossRef] [PubMed]
4. Hanson, L.A.; Korotkova, M. The role of breastfeeding in prevention of neonatal infection. Semin. Neonatol. 2002, 7, 275–281. [CrossRef]
5. Le Huërou-Luron, I.; Blat, S.; Boudry, G. Breast-v. formula-feeding: Impacts on the digestive tract and immediate and long-term health effects. Nutr. Res. Rev. 2010, 23, 23–36. [CrossRef] [PubMed]
6. Maidens, C.; Childs, C.; Przemska, A.; Dayel, I.B.; Yaqoob, P. Modulation of vaccine response by concomitant probiotic administration. Br. J. Clin. Pharmacol. 2013, 75, 663–670. [CrossRef] [PubMed]
7. Ashraf, R.; Shah, N.P. Immune system stimulation by probiotic microorganisms. Crit. Rev. Food Sci. Nutr. 2014, 54, 938–956. [CrossRef] [PubMed]
8. Soh, S.E.; Ong, D.Q.; Gerez, I.; Zhang, X.; Chollate, P.; Shek, L.P.; Lee, B.W.; Aw, M. Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant hepatitis B vaccination. Vaccine 2010, 28, 2577–2579. [CrossRef] [PubMed]
9. Rinne, M.; Kalliomaki, M.; Arvilommi, H.; Salminenet, S.; Isolauri, E. Effect of probiotics and breastfeeding on the bifidobacterium and lactobacillus/enterococcus microbiota and humoral immune responses. J. Pediatr. 2005, 147, 186–191. [CrossRef] [PubMed]
10. Mohan, R.; Koebnick, C.; Schildt, J.; Mueller, M.; Radke, M.; Blaut, Me. Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr. Res. 2008, 64, 418–422. [CrossRef] [PubMed]
11. Holscher, H.D.; Czerkies, L.A.; Cekola, P.; Litov, R.; Benbow, M.; Santema, S.; Alexander, D.D.; Perez, V.; Sun, S.; Saavedra, J.M.; et al. Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula-fed infants: A randomized, double-blind, controlled trial. J. Parenter. Enter. Nutr. 2012, 36, 106SS–117SS. [CrossRef] [PubMed]
12. Picard, C.; Fioramonti, J.; Francois, A.; Robinson, T.; Neant, F.; Matuchansky, C. Review article: Bifidobacteria as probiotic agents—physiological effects and clinical benefits. Aliment. Pharmacol. Ther. 2005, 22, 495–512. [CrossRef] [PubMed]
13. Nakamura, Y.; Terahara, M.; Yajima, M.; Moro, I. Effect of Bifidobacterium bifidum OLB6377 and Bifidobacterium bifidum OLB6378 on expression of the human polymeric immunoglobulin receptor(pIgR). Dig. Org. Mucos Immunol. 2005, 42, 53–56. (In Japanese)
14. Totsu, S.; Yamasaki, C.; Terahara, M.; Uchiyama, A.; Kusuda, S.; Probiotics Study Group in Japan. Bifidobacterium and enteral feeding in preterm infants: Cluster-randomized trial. Pediatr. Int. 2014, 56, 714–719. [PubMed]
15. Adams, C.A. The probiotic paradox: Live and dead cells are biological response modifiers. Nutr. Res. Rev. 2010, 23, 37–46. [CrossRef] [PubMed]
16. Lee, H.A.; Kim, H.; Lee, K.W.; Park, K.Y. Dead nano-sized Lactobacillus plantarum inhibits azoxymethane/dextran sulfate sodium-induced colon cancer in balb/c mice. J. Med. Food 2015, 18, 1400–1405. [CrossRef] [PubMed]
17. Nakamura, Y.; Terahara, M.; Iwamoto, T.; Yamada, K.; Asano, M.; Kakuta, S.; Iwakura, Y.; Totsuka, M. Upregulation of polymeric immunoglobulin receptor expression by the heat-inactivated potential probiotic Bifidobacterium bifidum OLB6378 in a mouse intestinal explant model. Scand. J. Immunol. 2012, 75, 176–183. [CrossRef] [PubMed]
18. Toshimitsu, T.; Nakamura, M.; Ikegami, S.; Terahara, M.; Itou, H. Strain-specific identification of Bifidobacterium bifidum OLB6378 by PCR. Biosci. Biotechnol. Biochem. 2013, 77, 572–576. [CrossRef] [PubMed]
19. Palmeira, P.; Quinello, C.; Silveira-Lessa, A.L.; Zago, C.A.; Carneiro-Sampaio, M. IgG placental transfer in healthy and pathological pregnancies. Clin. Dev. Immunol. 2012, 2012, 985646. [CrossRef] [PubMed]
20. Ballow, M.; Cates, K.L.; Rowe, J.C.; Goetz, C.; Desbonnet, C. Development of the immune system in very low birth weight (less than 1500 g) premature infants: Concentrations of plasma immunoglobulins and patterns of infections. Pediatr. Res. 1986, 20, 899–904. [CrossRef] [PubMed]
21. Stiehm, E.R.; Fudenberg, H.H. Serum levels of immune globulins in health and disease: A survey. Pediatrics 1966, 37, 715–727. [PubMed]
22. Maruyama, K.; Hida, M.; Kohgo, T.; Fukunaga, Y. Changes in salivary and fecal secretory IgA in infants under different feeding regimens. Pediatr. Int. 2009, 51, 342–345. [CrossRef] [PubMed]
23. Gleeson, M.; Cripps, A.W. Development of mucosal immunity in the first year of life and relationship to sudden infant death syndrome. FEMS Immunol. Med. Microbiol. 2004, 42, 21–33. [CrossRef] [PubMed]
24. Gleeson, M.; Cripps, A.W.; Clancy, R.L.; Husband, A.J.; Hensley, M.J.; Leeder, S.R. Ontogeny of the secretory immune system in man. Aust. N. Z. J. Med. 1982, 12, 255–258. [CrossRef] [PubMed]
25. Stephens, S. Development of secretory immunity in breast fed and bottle fed infants. Arch. Dis. Child. 1986, 6, 263–269. [CrossRef]
26. Kaetzel, C.S. Cooperativity among secretory IgA, the polymeric immunoglobulin receptor, and the gut microbiota promotes host-microbial mutualism. Immunol. Lett. 2014, 162, 10–21. [CrossRef] [PubMed]
27. Cross, M.L.; Stevenson, L.M.; Gill, H.S. Anti-allergy properties of fermented foods: An important immunoregulatory mechanism of lactic acid bacteria? Int. Immunopharmacol. 2001, 1, 891–901. [CrossRef]
28. Kikuchi, Y.; Yoshida, H.; Ogita, T.; Okita, K.; Fukudome, S.; Suzuki, T.; Tanabe, S. In vivo dose response and in vitro mechanistic analysis of enhanced immunoglobulin a production by Lactobacillus plantarum AYA. Biosci. Microbiota Food Health 2015, 34, 53–58. [CrossRef] [PubMed]
29. Boyle, R.J.; Robins-Browne, R.M.; Tang, M.L. Probiotic use in clinical practice: What are the risks? Am. J. Clin. Nutr. 2006, 83, 1256–1264. [PubMed]
30. Hickey, L.; Garland, S.M.; Jacobs, S.E.; O’Donnell, C.P.; Tabrizi, S.N.; ProPrems Study Group. Cross-colonization of infants with probiotic organisms in a neonatal unit. J. Hosp. Infect. 2014, 88, 226–229. [CrossRef] [PubMed]
31. Rao, S.C.; Athalye-Jape, G.K.; Deshpande, G.C.; Simmer, K.N.; Patole, S.K. Probiotic supplementation and late-onset sepsis in preterm infants: A meta-analysis. Pediatrics 2016, 137, e20153684. [CrossRef] [PubMed]
32. Carlier, F.M.; Sibille, Y.; Pilette, C. The epithelial barrier and immunoglobulin a system in allergy. Clin. Exp. Allergy 2016, 46, 1372–1388. [CrossRef] [PubMed]